T1	PROC 46 60	Ensayo clínico
#1	AnnotatorNotes T1	C0008976; Clinical Trials; Research Activity
T2	ANAT 182 198	ductus arterioso
#2	AnnotatorNotes T2	C0013273; Structure of ductus arteriosus; Embryonic Structure | C1269536; Entire ductus arteriosus; Embryonic Structure
T3	PROC 118 142	pautas de administración
#3	AnnotatorNotes T3	C0040808; Treatment Protocols; Therapeutic or Preventive Procedure
T4	CHEM 146 156	ibuprofeno
#4	AnnotatorNotes T4	C0020740; ibuprofen; Organic Chemical · Pharmacologic Substance
T5	PROC 166 177	tratamiento
#5	AnnotatorNotes T5	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T6	DISO 182 210	ductus arterioso persistente
#6	AnnotatorNotes T6	C0013274; Patent ductus arteriosus; Congenital Abnormality
T7	PROC 212 238	guiado por ecocardiografía
#7	AnnotatorNotes T7	C0442973; Ultrasonic guidance procedure; Diagnostic Procedure
T8	PROC 261 326	Ensayo clínico fase III, aleatorizado, multicéntrico, doble ciego
T9	PROC 344 368	pautas de administración
#8	AnnotatorNotes T9	C0040808; Treatment Protocols; Therapeutic or Preventive Procedure
T10	CHEM 373 383	ibuprofeno
#9	AnnotatorNotes T10	C0020740; ibuprofen; Organic Chemical · Pharmacologic Substance
T11	PROC 390 401	tratamiento
#10	AnnotatorNotes T11	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T12	DISO 406 434	ductus arterioso persistente
#11	AnnotatorNotes T12	C0013274; Patent ductus arteriosus; Congenital Abnormality
T13	PROC 435 445	eco-guiado
#12	AnnotatorNotes T13	C0442973; Ultrasonic guidance procedure; Diagnostic Procedure
T14	DISO 506 534	ductus arterioso persistente
#13	AnnotatorNotes T14	C0013274; Patent ductus arteriosus; Congenital Abnormality
T15	DISO 579 589	prematuros
#14	AnnotatorNotes T15	C0021294; Infant, Premature; Finding | C0728731; Prematurity of fetus; Finding
T16	PROC 673 698	tratamiento farmacológico
#15	AnnotatorNotes T16	C0013216; Pharmacotherapy; Therapeutic or Preventive Procedure
T17	DISO 831 854	alteraciones congénitas
T18	DISO 865 888	Cardiopatías congénitas
#16	AnnotatorNotes T18	C0018798; Congenital Heart Defects; Congenital Abnormality
T19	DISO 942 953	Oligoanuria
#17	AnnotatorNotes T19	C0028962; Anuria and oliguria; Sign or Symptom | C3887784; Decreased urine output; Finding
T20	DISO 980 1005	Sangrado intraventricular
#18	AnnotatorNotes T20	C0240059; Ventricular hemorrhage; Pathologic Function
T21	DISO 1038 1073	infarto hemorrágico periventricular
#19	AnnotatorNotes T21	C3278201; Periventricular hemorrhagic infarction; Finding
T22	ANAT 1058 1073	periventricular
#20	AnnotatorNotes T22	C4331000; Periventricular Region; Body Location or Region
T23	CHEM 1087 1097	Creatinina
#21	AnnotatorNotes T23	C0010294; creatinine; Biologically Active Substance · Organic Chemical
T24	ANAT 1098 1104	sérica
#22	AnnotatorNotes T24	C0229671; Serum; Body Substance | C0588987; Serum product; Body Substance
T25	DISO 1139 1158	isquemia intestinal
#23	AnnotatorNotes T25	C2004435; Vascular insufficiency of intestine; Disease or Syndrome
T26	ANAT 102 112	intestinal
#24	AnnotatorNotes T26	C0021853; Intestines; Body Part, Organ, or Organ Component | C1318303; Entire intestine; Body Part, Organ, or Organ Component
T27	ANAT 637 639	DA
T28	PROC 702 726	Consentimiento informado
#25	AnnotatorNotes T28	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T29	ANAT 472 482	intestinal
#26	AnnotatorNotes T29	C0021853; Intestines; Body Part, Organ, or Organ Component | C1318303; Entire intestine; Body Part, Organ, or Organ Component
T30	PROC 917 931	administración
#27	AnnotatorNotes T30	C1533734; Administration procedure; Therapeutic or Preventive Procedure
T31	ANAT 989 1005	intraventricular
#28	AnnotatorNotes T31	C1517569; Intraventricular; Body Location or Region
T32	PROC 1087 1104	Creatinina sérica
#29	AnnotatorNotes T32	C0201976; Creatinine measurement, serum (procedure); Laboratory Procedure
T33	PROC 791 805	Consentimiento
#30	AnnotatorNotes T33	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T34	ANAT 1148 1158	intestinal
#31	AnnotatorNotes T34	C0021853; Intestines; Body Part, Organ, or Organ Component | C1318303; Entire intestine; Body Part, Organ, or Organ Component
T35	CHEM 935 937	IB
T36	DISO 1022 1025	HIV
T37	ANAT 406 422	ductus arterioso
#32	AnnotatorNotes T37	C0013273; Structure of ductus arteriosus; Embryonic Structure | C1269536; Entire ductus arteriosus; Embryonic Structure 
T38	ANAT 506 522	ductus arterioso
#33	AnnotatorNotes T38	C0013273; Structure of ductus arteriosus; Embryonic Structure | C1269536; Entire ductus arteriosus; Embryonic Structure
T39	Date 13 17	2016
T40	Duration 594 613	menos de 33 semanas
T42	LIVB 742 761	representante legal
#34	AnnotatorNotes T42	C4288823; Legal Representative for the Study; Human
T43	PHYS 955 963	diuresis
#35	AnnotatorNotes T43	C0012797; Diuresis; Organ or Tissue Function
T44	Date 1006 1014	reciente
T47	Spec_cue 1119 1127	sospecha
T48	LIVB 564 589	Recién nacidos prematuros
#36	AnnotatorNotes T48	C4048294; Preterm Infant; Age Group
T41	Neg_cue 806 814	denegado
T45	PHYS 622 633	gestacional
#37	AnnotatorNotes T45	C0032961; Pregnancy; Organism Function
T46	PROC 617 633	edad gestacional
#38	AnnotatorNotes T46	C4040272; Assessment of fetal gestational age; Health Care Activity
A1	Assertion T25 Speculated
A2	Assertion T33 Negated
A3	Population_data T48 Age
A4	Assertion T30 Contraindicated
A5	Assertion T35 Contraindicated
#39	AnnotatorNotes T8	C0282461; Phase 3 Clinical Trials; Research Activity + C1096776; Multicenter Study; Research Activity + C0013072; Double-Blind Method; Research Activity + C0206034; Clinical Trials, Randomized; Research Activity
#40	AnnotatorNotes T27	C0013273; Structure of ductus arteriosus; Embryonic Structure | C1269536; Entire ductus arteriosus; Embryonic Structure
#41	AnnotatorNotes T17	C0242354; Congenital Disorders; Disease or Syndrome
#42	AnnotatorNotes T35	C0020740; ibuprofen; Organic Chemical · Pharmacologic Substance
#43	AnnotatorNotes T36	C0240059; Ventricular hemorrhage; Pathologic Function
R1	Used_for Arg1:T4 Arg2:T3	
R2	Location_of Arg1:T2 Arg2:T6	
R3	Used_for Arg1:T10 Arg2:T9	
R4	Location_of Arg1:T37 Arg2:T12	
R5	Location_of Arg1:T38 Arg2:T14	
R6	Experiences Arg1:T48 Arg2:T15	
R7	Has_Duration_or_Interval Arg1:T45 Arg2:T40	
R8	Experiences Arg1:T48 Arg2:T46	
T49	Result_or_Value 640 648	≥ 1,5 mm
R9	Has_Result_or_Value Arg1:T27 Arg2:T49	
R10	Negation Arg1:T41 Arg2:T33	
T50	Quantifier_or_Qualifier 855 861	graves
R11	Has_Quantifier_or_Qualifier Arg1:T17 Arg2:T50	
R12	Used_for Arg1:T35 Arg2:T30	
T51	Result_or_Value 964 974	< 1cc/kg/h
R13	Has_Result_or_Value Arg1:T43 Arg2:T51	
R14	Location_of Arg1:T31 Arg2:T20	
R15	Overlap Arg1:T20 Arg2:T44	
T52	Quantifier_or_Qualifier 1015 1020	grave
R16	Has_Quantifier_or_Qualifier Arg1:T20 Arg2:T52	
T53	Quantifier_or_Qualifier 1026 1035	grado III
R17	Has_Quantifier_or_Qualifier Arg1:T36 Arg2:T53	
R18	Location_of Arg1:T22 Arg2:T21	
T54	Quantifier_or_Qualifier 1074 1081	extenso
R19	Has_Quantifier_or_Qualifier Arg1:T21 Arg2:T54	
R20	Overlap Arg1:T36 Arg2:T44	
R21	Overlap Arg1:T21 Arg2:T44	
R22	Location_of Arg1:T24 Arg2:T32	
T55	Result_or_Value 1105 1116	> 1,5 mg/dl
R23	Has_Result_or_Value Arg1:T32 Arg2:T55	
R24	Speculation Arg1:T47 Arg2:T25	
R25	Location_of Arg1:T34 Arg2:T25	
R26	Overlap Arg1:T3 Arg2:T7	
R27	Overlap Arg1:T5 Arg2:T7	
R28	Overlap Arg1:T11 Arg2:T13	
R29	Overlap Arg1:T9 Arg2:T13	
R31	Causes Arg1:T21 Arg2:T20	
#44	AnnotatorNotes T44	C0332185; Recent; Temporal Concept
#45	AnnotatorNotes T50	C1547227; Severe - Severity of Illness Code; Intellectual Product
#46	AnnotatorNotes T52	C1547227; Severe -Severity of Illness Code; Intellectual Product
#47	AnnotatorNotes T53	C0443323; Third degree; Qualitative Concept
R30	Overlap Arg1:T20 Arg2:T36	
#48	AnnotatorNotes T54	C0205231; Extensive; Qualitative Concept
A6	Experiencer T48 Patient
A7	Experiencer T42 Other
